Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2021

01-12-2021 | Coronavirus | Original investigation

Epicardial adipose tissue and severe Coronavirus Disease 19

Authors: Hélène Bihan, Richard Heidar, Aude Beloeuvre, Lucie Allard, Elise Ouedraogo, Sopio Tatulashvili, Yacine Tandjaoui, Stephane Gaudry, Pierre-Yves Brillet, Emmanuel Cosson

Published in: Cardiovascular Diabetology | Issue 1/2021

Login to get access

Abstract

Background

Both visceral adipose tissue and epicardial adipose tissue (EAT) have pro-inflammatory properties. The former is associated with Coronavirus Disease 19 (COVID-19) severity. We aimed to investigate whether an association also exists for EAT.

Material and methods

We retrospectively measured EAT volume using computed tomography (CT) scans (semi-automatic software) of inpatients with COVID-19 and analyzed the correlation between EAT volume and anthropometric characteristics and comorbidities. We then analyzed the clinicobiological and radiological parameters associated with severe COVID-19 (O2 \(\ge\) 6 l/min), intensive care unit (ICU) admission or death, and 25% or more CT lung involvement, which are three key indicators of COVID-19 severity.

Results

We included 100 consecutive patients; 63% were men, mean age was 61.8 ± 16.2 years, 47% were obese, 54% had hypertension, 42% diabetes, and 17.2% a cardiovascular event history. Severe COVID-19 (n = 35, 35%) was associated with EAT volume (132 ± 62 vs 104 ± 40 cm3, p = 0.02), age, ferritinemia, and 25% or more CT lung involvement. ICU admission or death (n = 14, 14%) was associated with EAT volume (153 ± 67 vs 108 ± 45 cm3, p = 0.015), hypertension and 25% or more CT lung involvement. The association between EAT volume and severe COVID-19 remained after adjustment for sex, BMI, ferritinemia and lung involvement, but not after adjustment for age. Instead, the association between EAT volume and ICU admission or death remained after adjustment for all five of these parameters.

Conclusions

Our results suggest that measuring EAT volume on chest CT scans at hospital admission in patients diagnosed with COVID-19 might help to assess the risk of disease aggravation.
Literature
1.
go back to reference Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obes Silver Spring Md. 2020;28(7):1195–9.CrossRef Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obes Silver Spring Md. 2020;28(7):1195–9.CrossRef
2.
go back to reference Petrilli CM, Jones SA, Yang J, Rajagopalan H, O’Donnell L, Chernyak Y, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;22(369):m1966.CrossRef Petrilli CM, Jones SA, Yang J, Rajagopalan H, O’Donnell L, Chernyak Y, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;22(369):m1966.CrossRef
3.
go back to reference COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med. 2021;47(1):60–73.CrossRef COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med. 2021;47(1):60–73.CrossRef
4.
go back to reference Caër C, Rouault C, Le Roy T, Poitou C, Aron-Wisnewsky J, Torcivia A, et al. Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue. Sci Rep. 2017;7(1):3000.PubMedPubMedCentralCrossRef Caër C, Rouault C, Le Roy T, Poitou C, Aron-Wisnewsky J, Torcivia A, et al. Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue. Sci Rep. 2017;7(1):3000.PubMedPubMedCentralCrossRef
5.
go back to reference Stefan N, Birkenfeld AL, Schulze MB, Ludwig DS. Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol. 2020;16(7):341–2.PubMedCrossRefPubMedCentral Stefan N, Birkenfeld AL, Schulze MB, Ludwig DS. Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol. 2020;16(7):341–2.PubMedCrossRefPubMedCentral
6.
go back to reference Sahakyan KR, Somers VK, Rodriguez-Escudero JP, Hodge DO, Carter RE, Sochor O, et al. Normal-weight central obesity: implications for total and cardiovascular mortality. Ann Intern Med. 2015;163(11):827–35.PubMedPubMedCentralCrossRef Sahakyan KR, Somers VK, Rodriguez-Escudero JP, Hodge DO, Carter RE, Sochor O, et al. Normal-weight central obesity: implications for total and cardiovascular mortality. Ann Intern Med. 2015;163(11):827–35.PubMedPubMedCentralCrossRef
7.
8.
go back to reference Watanabe M, Caruso D, Tuccinardi D, Risi R, Zerunian M, Polici M, et al. Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19. Metabolism. 2020;111:154319.PubMedPubMedCentralCrossRef Watanabe M, Caruso D, Tuccinardi D, Risi R, Zerunian M, Polici M, et al. Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19. Metabolism. 2020;111:154319.PubMedPubMedCentralCrossRef
9.
go back to reference Villasante Fricke AC, Iacobellis G. Epicardial adipose tissue: clinical biomarker of cardio-metabolic risk. Int J Mol Sci. 2019;20(23):5989.PubMedCentralCrossRef Villasante Fricke AC, Iacobellis G. Epicardial adipose tissue: clinical biomarker of cardio-metabolic risk. Int J Mol Sci. 2019;20(23):5989.PubMedCentralCrossRef
10.
go back to reference Iacobellis G, Barbaro G. Epicardial adipose tissue feeding and overfeeding the heart. Nutr Burbank Los Angel Cty Calif. 2019;59:1–6.CrossRef Iacobellis G, Barbaro G. Epicardial adipose tissue feeding and overfeeding the heart. Nutr Burbank Los Angel Cty Calif. 2019;59:1–6.CrossRef
11.
go back to reference Christensen RH, von Scholten BJ, Hansen CS, Jensen MT, Vilsbøll T, Rossing P, et al. Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes. Cardiovasc Diabetol. 2019;18(1):114.PubMedPubMedCentralCrossRef Christensen RH, von Scholten BJ, Hansen CS, Jensen MT, Vilsbøll T, Rossing P, et al. Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes. Cardiovasc Diabetol. 2019;18(1):114.PubMedPubMedCentralCrossRef
12.
go back to reference Yamada H, Sata M. Role of pericardial fat: the good, the bad and the ugly. J Cardiol. 2015;65(1):2–4.PubMedCrossRef Yamada H, Sata M. Role of pericardial fat: the good, the bad and the ugly. J Cardiol. 2015;65(1):2–4.PubMedCrossRef
13.
go back to reference Hirata Y, Tabata M, Kurobe H, Motoki T, Akaike M, Nishio C, et al. Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J Am Coll Cardiol. 2011;58(3):248–55.PubMedCrossRef Hirata Y, Tabata M, Kurobe H, Motoki T, Akaike M, Nishio C, et al. Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J Am Coll Cardiol. 2011;58(3):248–55.PubMedCrossRef
14.
go back to reference Shimabukuro M, Hirata Y, Tabata M, Dagvasumberel M, Sato H, Kurobe H, et al. Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 2013;33(5):1077–84.PubMedCrossRef Shimabukuro M, Hirata Y, Tabata M, Dagvasumberel M, Sato H, Kurobe H, et al. Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 2013;33(5):1077–84.PubMedCrossRef
15.
go back to reference Malavazos AE, Goldberger JJ, Iacobellis G. Does epicardial fat contribute to COVID-19 myocardial inflammation? Eur Heart J. 2020;41(24):2333.PubMedCrossRef Malavazos AE, Goldberger JJ, Iacobellis G. Does epicardial fat contribute to COVID-19 myocardial inflammation? Eur Heart J. 2020;41(24):2333.PubMedCrossRef
16.
go back to reference Grodecki K, Lin A, Razipour A, Cadet S, McElhinney PA, Chan C, et al. Epicardial adipose tissue is associated with extent of pneumonia and adverse outcomes in patients with COVID-19. Metabolism. 2020;115:154436.PubMedPubMedCentralCrossRef Grodecki K, Lin A, Razipour A, Cadet S, McElhinney PA, Chan C, et al. Epicardial adipose tissue is associated with extent of pneumonia and adverse outcomes in patients with COVID-19. Metabolism. 2020;115:154436.PubMedPubMedCentralCrossRef
17.
go back to reference Deng M, Qi Y, Deng L, Wang H, Xu Y, Li Z, et al. Obesity as a potential predictor of disease severity in young COVID-19 patients: a retrospective study. Obes Silver Spring Md. 2020;28(10):1815–25.CrossRef Deng M, Qi Y, Deng L, Wang H, Xu Y, Li Z, et al. Obesity as a potential predictor of disease severity in young COVID-19 patients: a retrospective study. Obes Silver Spring Md. 2020;28(10):1815–25.CrossRef
18.
go back to reference Allard L, Ouedraogo E, Molleville J, Bihan H, Giroux-Leprieur B, Sutton A, et al. Malnutrition: percentage and association with prognosis in patients hospitalized for Coronavirus disease 2019. Nutrients. 2020;12(12):3679.PubMedCentralCrossRef Allard L, Ouedraogo E, Molleville J, Bihan H, Giroux-Leprieur B, Sutton A, et al. Malnutrition: percentage and association with prognosis in patients hospitalized for Coronavirus disease 2019. Nutrients. 2020;12(12):3679.PubMedCentralCrossRef
19.
go back to reference Guaraldi G, Scaglioni R, Zona S, Orlando G, Carli F, Ligabue G, et al. Epicardial adipose tissue is an independent marker of cardiovascular risk in HIV-infected patients. AIDS Lond Engl. 2011;25(9):1199–205.CrossRef Guaraldi G, Scaglioni R, Zona S, Orlando G, Carli F, Ligabue G, et al. Epicardial adipose tissue is an independent marker of cardiovascular risk in HIV-infected patients. AIDS Lond Engl. 2011;25(9):1199–205.CrossRef
21.
go back to reference Lesourd B, Ziegler F, Aussel C. Nutrition in the elderly: importance and traps of biological investigations. Ann Biol Clin (Paris). 2001;59(4):445–52. Lesourd B, Ziegler F, Aussel C. Nutrition in the elderly: importance and traps of biological investigations. Ann Biol Clin (Paris). 2001;59(4):445–52.
22.
go back to reference Dey D, Nakazato R, Li D, Berman DS. Epicardial and thoracic fat - Noninvasive measurement and clinical implications. Cardiovasc Diagn Ther. 2012;2(2):85–93.PubMedPubMedCentral Dey D, Nakazato R, Li D, Berman DS. Epicardial and thoracic fat - Noninvasive measurement and clinical implications. Cardiovasc Diagn Ther. 2012;2(2):85–93.PubMedPubMedCentral
23.
go back to reference Silaghi A, Piercecchi-Marti M-D, Grino M, Leonetti G, Alessi MC, Clement K, et al. Epicardial adipose tissue extent: relationship with age, body fat distribution, and coronaropathy. Obes Silver Spring Md. 2008;16(11):2424–30.CrossRef Silaghi A, Piercecchi-Marti M-D, Grino M, Leonetti G, Alessi MC, Clement K, et al. Epicardial adipose tissue extent: relationship with age, body fat distribution, and coronaropathy. Obes Silver Spring Md. 2008;16(11):2424–30.CrossRef
24.
go back to reference Rabkin SW. The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis. Metab Syndr Relat Disord. 2014;12(1):31–42.PubMedCrossRef Rabkin SW. The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis. Metab Syndr Relat Disord. 2014;12(1):31–42.PubMedCrossRef
25.
go back to reference Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS, et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation. 2008;117(5):605–13.PubMedCrossRef Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS, et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation. 2008;117(5):605–13.PubMedCrossRef
26.
go back to reference Christensen RH, von Scholten BJ, Lehrskov LL, Rossing P, Jørgensen PG. Epicardial adipose tissue: an emerging biomarker of cardiovascular complications in type 2 diabetes? Ther Adv Endocrinol Metab. 2020;11:204201882092882.CrossRef Christensen RH, von Scholten BJ, Lehrskov LL, Rossing P, Jørgensen PG. Epicardial adipose tissue: an emerging biomarker of cardiovascular complications in type 2 diabetes? Ther Adv Endocrinol Metab. 2020;11:204201882092882.CrossRef
27.
go back to reference Park J-S, Ahn S-G, Hwang J-W, Lim H-S, Choi B-J, Choi S-Y, et al. Impact of body mass index on the relationship of epicardial adipose tissue to metabolic syndrome and coronary artery disease in an Asian population. Cardiovasc Diabetol. 2010;9:29.PubMedPubMedCentralCrossRef Park J-S, Ahn S-G, Hwang J-W, Lim H-S, Choi B-J, Choi S-Y, et al. Impact of body mass index on the relationship of epicardial adipose tissue to metabolic syndrome and coronary artery disease in an Asian population. Cardiovasc Diabetol. 2010;9:29.PubMedPubMedCentralCrossRef
28.
go back to reference Moharram MA, Aitken-Buck HM, Reijers R, van Hout I, Williams MJ, Jones PP, et al. Correlation between epicardial adipose tissue and body mass index in New Zealand ethnic populations. N Z Med J. 2020;133(1516):22–32.PubMed Moharram MA, Aitken-Buck HM, Reijers R, van Hout I, Williams MJ, Jones PP, et al. Correlation between epicardial adipose tissue and body mass index in New Zealand ethnic populations. N Z Med J. 2020;133(1516):22–32.PubMed
29.
go back to reference Kompaniyets L, Goodman AB, Belay B, Freedman DS, Sucosky MS, Lange SJ, et al. Body Mass Index and risk for COVID-19–related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death—United States, March–December 2020. MMWR Morb Mortal Wkly Rep. 2021;70(10):355–61.PubMedPubMedCentralCrossRef Kompaniyets L, Goodman AB, Belay B, Freedman DS, Sucosky MS, Lange SJ, et al. Body Mass Index and risk for COVID-19–related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death—United States, March–December 2020. MMWR Morb Mortal Wkly Rep. 2021;70(10):355–61.PubMedPubMedCentralCrossRef
30.
go back to reference Abrishami A, Eslami V, Baharvand Z, Khalili N, Saghamanesh S, Zarei E, et al. Epicardial adipose tissue, inflammatory biomarkers and COVID-19: Is there a possible relationship? Int Immunopharmacol. 2020;90:107174.PubMedPubMedCentralCrossRef Abrishami A, Eslami V, Baharvand Z, Khalili N, Saghamanesh S, Zarei E, et al. Epicardial adipose tissue, inflammatory biomarkers and COVID-19: Is there a possible relationship? Int Immunopharmacol. 2020;90:107174.PubMedPubMedCentralCrossRef
31.
go back to reference Eslami V, Abrishami A, Zarei E, Khalili N, Baharvand Z, Sanei-Taheri M. The association of CT-measured cardiac indices with lung involvement and clinical outcome in patients with COVID-19. Acad Radiol. 2021;28(1):8–17.PubMedCrossRef Eslami V, Abrishami A, Zarei E, Khalili N, Baharvand Z, Sanei-Taheri M. The association of CT-measured cardiac indices with lung involvement and clinical outcome in patients with COVID-19. Acad Radiol. 2021;28(1):8–17.PubMedCrossRef
32.
33.
go back to reference Sardu C, Gargiulo G, Esposito G, Paolisso G, Marfella R. Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19. Cardiovasc Diabetol. 2020;19(1):76.PubMedPubMedCentralCrossRef Sardu C, Gargiulo G, Esposito G, Paolisso G, Marfella R. Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19. Cardiovasc Diabetol. 2020;19(1):76.PubMedPubMedCentralCrossRef
34.
go back to reference The “Diabetes and Cardiovascular Disease (D&CVD)” Study Group of the European Association for the Study of Diabetes (EASD), Ceriello A, Standl E, Catrinoiu D, Itzhak B, Lalic NM, et al. Issues for the management of people with diabetes and COVID-19 in ICU. Cardiovasc Diabetol. 2020;19(1):114.CrossRef The “Diabetes and Cardiovascular Disease (D&CVD)” Study Group of the European Association for the Study of Diabetes (EASD), Ceriello A, Standl E, Catrinoiu D, Itzhak B, Lalic NM, et al. Issues for the management of people with diabetes and COVID-19 in ICU. Cardiovasc Diabetol. 2020;19(1):114.CrossRef
35.
go back to reference Dozio E, Malavazos AE, Vianello E, Briganti S, Dogliotti G, Bandera F, et al. Interleukin-15 and soluble interleukin-15 receptor α in coronary artery disease patients: association with epicardial fat and indices of adipose tissue distribution. PLoS ONE. 2014;9(3):e90960.PubMedPubMedCentralCrossRef Dozio E, Malavazos AE, Vianello E, Briganti S, Dogliotti G, Bandera F, et al. Interleukin-15 and soluble interleukin-15 receptor α in coronary artery disease patients: association with epicardial fat and indices of adipose tissue distribution. PLoS ONE. 2014;9(3):e90960.PubMedPubMedCentralCrossRef
36.
go back to reference Parisi V, Cabaro S, D’Esposito V, Petraglia L, Conte M, Campana P, et al. Epicardial adipose tissue and IL-13 response to myocardial injury drives left ventricular remodeling after st elevation myocardial infarction. Front Physiol. 2020;11:575181.PubMedPubMedCentralCrossRef Parisi V, Cabaro S, D’Esposito V, Petraglia L, Conte M, Campana P, et al. Epicardial adipose tissue and IL-13 response to myocardial injury drives left ventricular remodeling after st elevation myocardial infarction. Front Physiol. 2020;11:575181.PubMedPubMedCentralCrossRef
37.
go back to reference Fu C-P, Sheu WH-H, Lee I-T, Tsai I-C, Lee W-J, Liang K-W, et al. Effects of weight loss on epicardial adipose tissue thickness and its relationship between serum soluble CD40 ligand levels in obese men. Clin Chim Acta Int J Clin Chem. 2013;421:98–103.CrossRef Fu C-P, Sheu WH-H, Lee I-T, Tsai I-C, Lee W-J, Liang K-W, et al. Effects of weight loss on epicardial adipose tissue thickness and its relationship between serum soluble CD40 ligand levels in obese men. Clin Chim Acta Int J Clin Chem. 2013;421:98–103.CrossRef
38.
go back to reference Sekikawa A, Kadowaki T, Curb JD, Evans RW, Maegawa H, Abbott RD, et al. Circulating levels of 8 cytokines and marine n-3 fatty acids and indices of obesity in Japanese, white, and Japanese American middle-aged men. J Interferon Cytokine Res. 2010;30(7):541–8.PubMedPubMedCentralCrossRef Sekikawa A, Kadowaki T, Curb JD, Evans RW, Maegawa H, Abbott RD, et al. Circulating levels of 8 cytokines and marine n-3 fatty acids and indices of obesity in Japanese, white, and Japanese American middle-aged men. J Interferon Cytokine Res. 2010;30(7):541–8.PubMedPubMedCentralCrossRef
39.
go back to reference Kim I-C, Han S. Epicardial adipose tissue: fuel for COVID-19-induced cardiac injury? Eur Heart J. 2020;41(24):2334–5.PubMedCrossRef Kim I-C, Han S. Epicardial adipose tissue: fuel for COVID-19-induced cardiac injury? Eur Heart J. 2020;41(24):2334–5.PubMedCrossRef
40.
go back to reference Cosson E, Nguyen MT, Rezgani I, Tatulashvili S, Sal M, Berkane N, et al. Epicardial adipose tissue volume and coronary calcification among people living with diabetes: a cross-sectional study. Cardiovasc Diabetol. 2021;20(1):35.PubMedPubMedCentralCrossRef Cosson E, Nguyen MT, Rezgani I, Tatulashvili S, Sal M, Berkane N, et al. Epicardial adipose tissue volume and coronary calcification among people living with diabetes: a cross-sectional study. Cardiovasc Diabetol. 2021;20(1):35.PubMedPubMedCentralCrossRef
41.
go back to reference Cordeiro AC, Amparo FC, Oliveira MAC, Amodeo C, Smanio P, Pinto IMF, et al. Epicardial fat accumulation, cardiometabolic profile and cardiovascular events in patients with stages 3–5 chronic kidney disease. J Intern Med. 2015;278(1):77–87.PubMedCrossRef Cordeiro AC, Amparo FC, Oliveira MAC, Amodeo C, Smanio P, Pinto IMF, et al. Epicardial fat accumulation, cardiometabolic profile and cardiovascular events in patients with stages 3–5 chronic kidney disease. J Intern Med. 2015;278(1):77–87.PubMedCrossRef
42.
go back to reference Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811–8.CrossRefPubMed Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811–8.CrossRefPubMed
43.
go back to reference Kim I-C, Kim JY, Kim HA, Han S. COVID-19-related myocarditis in a 21-year-old female patient. Eur Heart J. 2020;41(19):1859.PubMedCrossRef Kim I-C, Kim JY, Kim HA, Han S. COVID-19-related myocarditis in a 21-year-old female patient. Eur Heart J. 2020;41(19):1859.PubMedCrossRef
44.
go back to reference Vasques ACJ, Pareja JC, Souza JRM, Yamanaka A, de Oliveira da MS, Novaes FS, et al. Epicardial and pericardial fat in type 2 diabetes: favourable effects of biliopancreatic diversion. Obes Surg. 2015;25(3):477–85.PubMedCrossRef Vasques ACJ, Pareja JC, Souza JRM, Yamanaka A, de Oliveira da MS, Novaes FS, et al. Epicardial and pericardial fat in type 2 diabetes: favourable effects of biliopancreatic diversion. Obes Surg. 2015;25(3):477–85.PubMedCrossRef
45.
go back to reference Launbo N, Zobel EH, von Scholten BJ, Faerch K, Jørgensen PG, Christensen RH. Targeting epicardial adipose tissue with exercise, diet, bariatric surgery or pharmaceutical interventions: a systematic review and meta-analysis. Obes Rev. 2021;22(1):e13136.PubMedCrossRef Launbo N, Zobel EH, von Scholten BJ, Faerch K, Jørgensen PG, Christensen RH. Targeting epicardial adipose tissue with exercise, diet, bariatric surgery or pharmaceutical interventions: a systematic review and meta-analysis. Obes Rev. 2021;22(1):e13136.PubMedCrossRef
46.
go back to reference Commandeur F, Goeller M, Razipour A, Cadet S, Hell MM, Kwiecinski J, et al. Fully automated CT quantification of epicardial adipose tissue by deep learning: a multicenter study. Radiol Artif Intell. 2019;1(6):e190045.PubMedPubMedCentralCrossRef Commandeur F, Goeller M, Razipour A, Cadet S, Hell MM, Kwiecinski J, et al. Fully automated CT quantification of epicardial adipose tissue by deep learning: a multicenter study. Radiol Artif Intell. 2019;1(6):e190045.PubMedPubMedCentralCrossRef
47.
go back to reference Liu Z, Wang S, Wang Y, Zhou N, Shu J, Stamm C, et al. Association of epicardial adipose tissue attenuation with coronary atherosclerosis in patients with a high risk of coronary artery disease. Atherosclerosis. 2019;284:230–6.PubMedCrossRef Liu Z, Wang S, Wang Y, Zhou N, Shu J, Stamm C, et al. Association of epicardial adipose tissue attenuation with coronary atherosclerosis in patients with a high risk of coronary artery disease. Atherosclerosis. 2019;284:230–6.PubMedCrossRef
Metadata
Title
Epicardial adipose tissue and severe Coronavirus Disease 19
Authors
Hélène Bihan
Richard Heidar
Aude Beloeuvre
Lucie Allard
Elise Ouedraogo
Sopio Tatulashvili
Yacine Tandjaoui
Stephane Gaudry
Pierre-Yves Brillet
Emmanuel Cosson
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2021
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-021-01329-z

Other articles of this Issue 1/2021

Cardiovascular Diabetology 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine